Pre-Recorded Webinar: Psychedelics in Cancer Care: Evidence Informed Perspectives for Oncology Nurses
Psychedelics in Cancer Care: Evidence‑Informed Perspectives for Oncology Nurses explores the emerging role of psychedelic‑assisted approaches in supporting people living with cancer. This webinar examines current research related to alleviating psychological distress, anxiety, depression, existential suffering, and end‑of‑life fears, while supporting meaning‑making, emotional processing, and quality of life. Through an ethical and nursing‑focused lens, participants will gain a balanced, evidence‑informed understanding of this evolving area of care and the potential implications for oncology nursing practice.
Moderator: Dr. Lynda G. Balneaves, RN, PhD is a Full Professor and Associate Dean, Research in the College of Nursing, Rady Faculty of Health Sciences at the University of Manitoba. She has held academic positions at the University of Toronto and the University of British Columbia. Her research program focuses on the use of complementary and integrative therapies in the context of cancer and the development and evaluation of knowledge translation and decision support interventions for individuals living with cancer and oncology health professionals. She also engages in health policy and person-centred research related to medical and non-medical cannabis. She is a past president of the Society for Integrative Oncology and the former deputy director of the Canadian Consortium for the Investigation of Cannabinoids.
Presenter: Sarah Kratina, PhD, RN, is a clinician and researcher specializing in mental health, psychedelic interventions and drug policy. She is currently pursuing her MN-NP at the University of Alberta, and completed her BScN at McMaster University in Hamilton, Ontario, and her PhD at the University of Toronto in the Institute of Health Policy Management and Evaluation. Sarah’s research focuses on the intersection of psychedelic drug therapies and policy. She investigates the therapeutic potential of psychedelic interventions in various populations, including those with cancer, substance use disorders and those experiencing end-of-life distress. Clinically, Sarah works in the field of mental health and addictions. She works in emergency psychiatry, early psychosis intervention, and ketamine-assisted therapy.
Non-Members Click Here to Access Recording Members Click Here to Access Recording